BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33539620)

  • 1. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas.
    Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R
    Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence rate of infantile hemangioma after oral propranolol therapy.
    Frongia G; Byeon JO; Mehrabi A; Günther P
    Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Clinical Outcomes of Parotid Hemangiomas in the Pediatric Patient Population.
    Harris J; Phillips JD
    Ear Nose Throat J; 2021 Jun; 100(5):NP242-NP245. PubMed ID: 31565986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
    Xue L; Sun C; Xu DP; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
    Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
    Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol and infantile hemangiomas four years later: a systematic review.
    Marqueling AL; Oza V; Frieden IJ; Puttgen KB
    Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
    Kagami S; Kaneko M; Kishi A; Katori T
    J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
    Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
    J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new clinical and dermoscopic monitoring of infantile hemangiomas treated with oral propranolol.
    Tognetti L; Pianigiani E; Ierardi F; Cartocci A; Fiorani D; de Quattro M; Caini M; Oranges T; Cinotti E; Cevenini G; Rubegni P
    Dermatol Ther; 2020 Nov; 33(6):e14283. PubMed ID: 32896029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.
    Price CJ; Lattouf C; Baum B; McLeod M; Schachner LA; Duarte AM; Connelly EA
    Arch Dermatol; 2011 Dec; 147(12):1371-6. PubMed ID: 21844428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
    Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
    Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    Kagami S; Katori T
    J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.